RE: DHSC contract29 Jul 2022 16:19
Conflating issues.
Genesig three gene was not released until April 2021 , the DHSC contract in dispute was signed in Sept 2020.
Re that article , there are multiple and the lady in question has pursued Ajan Reginald relentlessly re Celixir and it's activities , is she right , is she wrong , I have no idea.
Without doubt he was struck off as a dentist.
Why did Novacyt employ him ?
Why did Roche employ him for 4 years too , and numerous other companies. I don't know .
Why did all the Novacyt staff appear very upset when he left ? After GM left and when D.A took over .
Would I have employed him ? NO , because I am a strong believer in clean hands, it avoids issues like the very ones which keep surfacing.
If Novacyt had any reservations about Genesig three gene then they would have pulled it from the CTDA validation waiting list. The fact it is not yet validated does not bother me as that is meaningless. We only got validation for Exsig a few weeks back and that has been in use since early in the pandemic.
Until the DHSC is settled we will have the same old articles regurgitated .
Who signed/ consigned is irrelevant , he was COO.
What was of interest to me was that in A Reginalds linked in it mentions training 90 hospitals to use POC testing. That is a lot of training and again I wonder if that is where the issue lies with the dispute , ease of use and speed of rollout hampered by training. I respect the poster Poidster and he thinks it is a disservice to NHS lab staff to think they required training but it would appear the statement in the CV contradicts that. I don't know.